Covered recipient · General Payments record
ROY ROSO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$970.47
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.62 | 12 |
| Travel and Lodging | $125.84 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $247.10 | 4 |
| ABBVIE INC. | $49.00 | 2 |
| Lilly USA, LLC | $39.33 | 2 |
| DePuy Synthes Sales Inc. | $24.40 | 1 |
| Xeris Pharmaceuticals, Inc. | $24.38 | 1 |
| Merck Sharp & Dohme Corporation | $20.73 | 1 |
| Acerta Pharma LLC | $20.00 | 1 |
| QIAGEN, LLC | $16.85 | 1 |
| GlaxoSmithKline, LLC. | $15.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.82 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108114685 | CMS |
| ABBVIE INC. | $27.18 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108114687 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105755981 | CMS |
| DePuy Synthes Sales Inc. | $24.40 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077881820 | CMS |
| GlaxoSmithKline, LLC. | $15.67 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116652725 | CMS |
| Lilly USA, LLC | $19.96 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933466 | CMS |
| Lilly USA, LLC | $19.37 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135955251 | CMS |
| Merck Sharp & Dohme LLC | $20.73 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141586369 | CMS |
| Nevro Corp. | $11.42 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130768728 | CMS |
| Nevro Corp. | $65.26 | 11/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1130768742 | CMS |
| Nevro Corp. | $60.58 | 11/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1130768740 | CMS |
| Nevro Corp. | $109.84 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130768744 | CMS |
| QIAGEN, LLC | $16.85 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153989777 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.38 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144637596 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.